11C-acetate

DRUG5 trials

Sponsors

University of Pennsylvania, Justin Sims, Abramson Cancer Center at Penn Medicine, Université de Sherbrooke

Conditions

Hepatocellular CarcinomaMild Cognitive ImpairmentProstate Cancer PatientsPulmonary HypertensionType2 Diabetes

Early Phase 1

C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer

CompletedNCT02715583

Abramson Cancer Center at Penn MedicineProstate Cancer Patients

Start: 2016-03-31End: 2020-09-25Updated: 2022-05-18

Phase 2

11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

CompletedNCT01917136

University of PennsylvaniaPulmonary Hypertension

Start: 2013-08-31End: 2018-10-31Updated: 2019-02-05

11C-acetate for Treatment Response After Radiotherapy for HCC

TerminatedNCT02549755

Justin SimsHepatocellular Carcinoma

Start: 2015-09-30End: 2016-10-31Updated: 2017-11-22

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

TerminatedNCT02811744

University of PennsylvaniaMild Cognitive Impairment

Start: 2017-01-31End: 2022-02-28Updated: 2024-01-11

Unknown Phase

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

CompletedNCT03188835

Université de SherbrookeType2 Diabetes

Start: 2017-05-23End: 2021-04-30Updated: 2025-01-27

Related Papers

High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake independently of changes in thermogenesis and the gut microbiome.

2022-09-0121 citations